Discover how CDK12 inhibitors are revolutionizing cancer immunotherapy by activating the STING pathway and turning cold tumors hot.
Explore how covalent CDK12 inhibitors are creating breakthroughs in triple-negative breast cancer treatment by targeting DNA repair mechanisms and inducing BRCAness.